Article
Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
Tumori - 1 Jan 2000
Capozzo Maria Anna, Schillani Giulia, Aguglia Eugenio, De Vanna Maurizio, Grassi Luigi, Conte Maria Anna, Giraldi Tullio
Abstract excerpt
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxiety, depression and mental adjustment to cancer in terminally ill cancer patients, considering also the 5-HTTLPR genetic polymorphism. A group of twenty-one consecutive patients admitted to the hosp...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
